Cassava Sciences
Presence
Cassava Sciences is one of the...
Cassava Sciences is a company listed under the stock ticker SAVA (US).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Cassava Sciences
- Remi Barbier, Chairman of the Board, President, Chief Executive Of...
- Robert Gussin, Director
- Sanford Robertson, Director
Popular executive movements at Cassava Sciences
- Claude Nicaise has joined the company as Director (posted on December 8 2023).
- Pierre Gravier has joined the company as Director (posted on December 8 2023).
- Robert Anderson has joined the company as Director (posted on December 8 2023).
Create your alert
to follow the executive moves at Cassava Sciences.
Pharmaceuticals
Cassava Sciences has 1,869 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Cassava Sciences
- RSS NEWS FEEDS | Cassava Sciences, Inc.
- Cassava Sciences’ Phase 2b Clinical Results in Alzheimer’s Selected as Late-Breaking News at CTAD 2020 | Cassava Sciences, Inc.
- Cassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimer’s Disease | Cassava Sciences, Inc.
- Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET | Cassava Sciences, Inc.
- Cassava Sciences to Present at H.C. Wainwright’s 22nd Annual Global Investment Conference | Cassava Sciences, Inc.
- Cassava Sciences Announces New Patent Grant | Cassava Sciences, Inc.
- Cassava Sciences Announces Lead Drug Candidate PTI-125 Is Assigned the Chemical Drug Name ‘sumifilam’ by USAN | Cassava Sciences, Inc.
- Cassava Sciences Announces Second Quarter 2020 Financial Results and Mid-year Business Review | Cassava Sciences, Inc.
- Cassava Sciences to Give Keynote Presentation on SavaDx at a Scientific Conference | Cassava Sciences, Inc.
- Cassava Sciences Added to Russell Indexes and Provides Phase 2b Study Update | Cassava Sciences, Inc.
- View more press releases Close
Social media about Cassava Sciences
- Cassava Sciences on Wikipedia, Google News & Yahoo Finance
- Cassava Sciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Robert Anderson 
Call Cassava Sciences at +1 512...
